Recursion Pharmaceuticals, Inc. (BMV:RXRX) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of class A common stock Announced: about US$200M · US$3.25 a share · Leerink Partners +4 Dealers: Leerink Partners (co-lead), Goldman Sachs & Co. LLC (co-lead), Morgan Stanley & Co. LLC (co-lead), Evercore Group L.L.C. (co-lead), Needham & Company, LLC Buyers: Janus Henderson Investors; Invus; Longaeva Partners; ARK Invest; Driehaus Capital Management Use of proceeds: Advance highest-conviction programs and deliver on upcoming clinical milestones | Oct 15, 2026 |